Publications by authors named "Shima Mimura"

Claim this Profile
D
Do Patients With Alcoholic Cirrhosis Accurately Recognize Their Alcohol Tolerance? A Study Comparing Self-Perception and ALDH2/ADH1B Genotype.
Tomoko Tadokoro, Mai Nakahara, Hiroki Tai, Rie Yano, Kei Takuma, Shima Mimura

Hepatol Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets.
Shima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, Mai Nakahara

J Clin Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular Carcinoma.
Atsuo Kitaoka, Kyoko Oura, Koji Fujita, Kota Sasaki, Fumiyuki Suetsugu, Shima Mimura

Anticancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) Inhibits the Proliferation of Gastric Cancer Cells and Alters microRNA Signatures.
Kota Sasaki, Koji Fujita, Shintaro Fujihara, Hisakazu Iwama, Atsuo Kitaoka, Shima Mimura

Anticancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma.
Kyoko Oura, Asahiro Morishita, Rie Yano, Takushi Manabe, Kei Takuma, Shima Mimura

J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma.
Kyoko Oura, Asahiro Morishita, Takushi Manabe, Kei Takuma, Mai Nakahara, Shima Mimura

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidewire-assisted successful closure of mis-punctured transverse colon during endoscopic ultrasound-guided cyst drainage.
Naoki Fujita, Hideki Kamada, Ryota Nakabayashi, Takuma Yamashita, Shima Mimura

DEN Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 Index.
Tomoko Tadokoro, Miwa Kawanaka, Hirokazu Takahashi, Shinichi Aishima, Wenli Zhao, Shima Mimura

Diagnostics (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Stem Resection for Control of Massive Bleeding After Polypectomy for a Pedunculated Colonic Polyp.
Shima Mimura, Kazuhiro Kozuka, Yui Kinouchi, Yukiko Koyama, Toshiharu Funaki

JGH Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up.
Shima Mimura, Masafumi Ono, Koji Fujita, Kei Takuma, Mai Nakahara

Intern Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectins and Liver Diseases.
Shima Mimura, Asahiro Morishita, Kyoko Oura, Kei Takuma, Mai Nakahara

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.
Tomoko Tadokoro, Joji Tani, Takushi Manabe, Kei Takuma, Mai Nakahara, Shima Mimura

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.
Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Shima Mimura

BMC Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of essential trace elements in the pathogenesis of hepatitis C virus‑related chronic liver disease and nonalcoholic steatohepatitis.
Takashi Himoto, Koji Fujita, Shima Mimura, Joji Tani, Asashiro Morishita

Exp Ther Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment.
Shima Mimura, Koji Fujita, Kei Takuma, Mai Nakahara, Kyoko Oura

Exp Ther Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival.
Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Shima Mimura

Cancer Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy.
Kyoko Oura, Asahiro Morishita, Takushi Manabe, Kei Takuma, Mai Nakahara, Shima Mimura

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy.
Kyoko Oura, Asahiro Morishita, Joji Tani, Takako Nomura, Takushi Manabe, Shima Mimura

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated interferon therapy-related microRNA-6126 downregulates sodium taurocholate cotransporting polypeptide expression in hepatocytes.
Koji Fujita, Hironori Nishitsuji, Hisakazu Iwama, Tomoko Tadokoro, Asahiro Morishita, Shima Mimura

Gene· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis.
Rie Hashimoto, Takashi Himoto, Mari Yamada, Shima Mimura, Koji Fujita

J Nutr Sci Vitaminol (Tokyo)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
Sae Hamaya, Shintaro Fujihara, Hisakazu Iwama, Koji Fujita, Tingting Shi, Shima Mimura

Anticancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines.
Kei Takuma, Shintaro Fujihara, Koji Fujita, Hisakazu Iwama, Mai Nakahara, Shima Mimura

Int J Mol Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of antibodies to Sp100 on a bacterial infection in patients with primary biliary cholangitis.
Takashi Himoto, Shuhei Yamamoto, Kaho Morimoto, Satoshi Tada, Shima Mimura

J Clin Lab Anal· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literature.
Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura

Mol Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study.
Joji Tani, Tomonori Senoh, Akio Moriya, Chikara Ogawa, Akihiro Deguchi, Shima Mimura

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis